Gerard J. Molloy

Gerard J. Molloy

Auto-generated profile, based on publicly available information

Gerard J. Molloy

School of Psychology, University of Galway, H91 TK33 Galway, Ireland

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in European Heart Journal
Verified
Journal Article
Closed access
JMJohn William McEvoy
John William McEvoy
CMCian P McCarthy
Cian P McCarthy
RBRosa Maria Bruno
Rosa Maria Bruno
SBSofie Brouwers
Sofie Brouwers
MCMichelle D Canavan
Michelle D Canavan
GKGulnoz Abdusattarovna Khamidullaeva
Gulnoz Abdusattarovna Khamidullaeva

1 March 2009 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
MHMark Hamer
Mark Hamer
YCYoichi Chida
Yoichi Chida
GMGerard J. Molloy
Gerard J. Molloy

1 December 2008 in JACC
Verified
Journal Article
Closed access
MHMark Hamer
Mark Hamer
GMGerard J. Molloy
Gerard J. Molloy
ESEmmanuel Stamatakis
Emmanuel Stamatakis

28 May 2005 in European Journal of Heart Failure
Verified
Journal Article
Closed access
GMGerard J. Molloy
Gerard J. Molloy
DJDerek W. Johnston
Derek W. Johnston
MWMiles D. Witham
Miles D. Witham
Background: There is increasing evidence that discharge planning and post-discharge support for CHF patients can contribute greatly to the medical management of heart failure (CHF) in the community and that the quality of the CHF patient’s close personal relationships can influence outcome in CHF. However, there has been little research on the impact of CHF on the family or the role of the family in the management of the condition. In this paper, we provide a review and analysis of studies that have explicitly investigated these issues in the informal carers of CHF patients. Results of the review: Sixteen papers were identified that examined the role and/or impact of informal caregiving for CHF patients. Our main findings were: demands specific to CHF caregiving were identified, e.g., monitoring complex medical and self-care regimen, disturbed sleep and frequent hospitalisation of patients. Relatively high levels of emotional distress were identified in CHF caregivers. Few studies explicitly investigated the role of informal carers in the management of CHF. Studies were limited in number, scope and quality. Conclusion: Caring for a family member with CHF can affect the well-being of those responsible for care, which may have consequences for the CHF patient’s health. Further studies are needed to clarify these issues and to examine the role of informal caregivers in the management of CHF in the community.

1 July 2009 in Social Science & Medicine
Verified
Journal Article
Open access
GMGerard John Molloy
Gerard John Molloy
ESEmmanuel Stamatakis
Emmanuel Stamatakis
GRGemma Randall
Gemma Randall
MHMark Hamer
Mark Hamer
The intermediate processes through which the various unmarried states can increase the risk of subsequent cardiovascular disease mortality are incompletely understood. An understanding of these processes and how they may vary by gender is important for understanding why marital status is strongly and robustly associated with subsequent cardiovascular disease. In a prospective study of 13,889 Scottish men and women (mean age 52.3, Standard Deviation: 11.8 yrs, range 35-95, 56.1% female) without a history of clinically diagnosed cardiovascular disease, we examined the extent to which health behaviours (smoking, alcohol, physical activity), psychological distress (General Health Questionnaire-12 item) and metabolic dysregulation (obesity levels, and the presence of hypertension and diabetes) account for the association between marital status and cardiovascular mortality. There were 258 cardiovascular deaths over an average follow up of 7.1 (Standard Deviation=3.3) years. The risk of cardiovascular mortality was greatest in single, never married men and separated/divorced women compared with those that were married in gender stratified models that were adjusted for age and socio-economic group. In models that were separately adjusted, behavioural factors explained up to 33%, psychological distress explained up to 10% and metabolic dysregulation up to 16% of the relative change in the hazard ratios in the observed significant associations between marital status and cardiovascular mortality. Behavioural factors were particularly important in accounting for the relationship between being separated/divorced and cardiovascular mortality in both men and women (33% and 21% of the relative change in the hazard ratios, respectively). The findings suggest that health behaviour, psychological distress and metabolic dysregulation data have varying explanatory power for understanding the observed relationship between cardiovascular disease mortality and unmarried states.

1 December 2017 in Journal Of Hypertension
Verified
Journal Article
Closed access
HDHannah Durand
Hannah Durand
PHPeter Hayes
Peter Hayes
EMEimear C. Morrissey
Eimear C. Morrissey
JNJohn Newell
John Newell
MCMonica Casey
Monica Casey
GMGerard J. Molloy
Gerard J. Molloy
Medication nonadherence is a known behavioural contributor to poor blood pressure (BP) control that puts patients with hypertension at elevated cardiovascular risk. Studies of medication adherence for apparent treatment-resistant hypertension (aTRH) vary significantly with respect to design, methods, and setting, and, as a result, have produced highly variable figures describing the prevalence of nonadherence. This review aimed to describe the prevalence and potential moderators of medication nonadherence estimates for aTRH. Systematic review and random effects meta-analysis. From an initial discovery of 921 studies, we identified 24 studies that measured medication adherence for patients with uncontrolled BP despite being prescribed three or more antihypertensive medications of different classes. By using a random effects model, the pooled prevalence of nonadherence was 31.2% (95% confidence interval = 20.2–44.7, I2 = 99.50) with nonadherence rates ranging from 3.3 to 86.1%. The strongest contributor to variance in nonadherence rates was the method of adherence assessment used. Studies that relied on self-report measures of adherence and/or pharmacy data reported lower levels of nonadherence than studies using more objective methods, such as liquid chromatography–mass spectrometry in single time-point bioassays or directly observed therapy. Findings indicate that medication nonadherence is a significant problem among aTRH patients. Identifying the most accurate and clinically feasible adherence assessment methods is necessary to reduce BP and cardiovascular morbidity, facilitate early behavioural intervention, prevent unnecessary diagnostic testing, and limit sometimes unnecessary and expensive BP lowering procedures. CRD42016028121.